To determine whether IGFBP-1 levels or the IGFBP-1/IGF-1 ratio could potentially be used as an independent prognostic factor for NPC patient outcome, we performed a multivariate analysis for survival using a multivariate Cox regression model with respect to OS and RFS (Table 3). The gene discussed is IGFBP1; the disease is nasopharyngeal carcinoma.